New drug combo aims to tame aggressive prostate cancer
NCT ID NCT04751929
Summary
This study is testing whether two drugs, abemaciclib and atezolizumab, can help control advanced prostate cancer that has spread and no longer responds to standard hormone treatments. The trial is enrolling men to receive one drug, the other, or both together, to see which approach is safest and most effective at shrinking tumors or stopping their growth. Researchers are also checking if the treatment works better for people whose tumors have a specific genetic change.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.